CME
Keeping Pace in Lung Cancer - HER2: Unveiling New Horizons in NSCLC Treatment
November 15, 2023
Guest: Jacob Sands, MD Host: Charu Aggarwal, MD, MPH We now have an FDA-approved targeted therapy to treat HER2-mutated NSCLC. Drs. Aggarwal and Sands discuss the most current clinical data, including management of adverse events.
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast
Gain access to Blubrry tools that help build your podcast, including free podcast stats!